Matrix Metalloproteinases in Remodeling of the Normal and Neoplastic Mammary Gland

Journal of Mammary Gland Biology and Neoplasia

Volumn 3, Issue 2, 1998, Pages 177-189

  Rudolph Owen, Laura A ^a   Matrisian, Lynn M ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Breast cancer; Collagenase; Gelatinase; Mammary development; Matrilysin; MMP; Stromelysin

Indexed keywords

MATRIX METALLOPROTEINASE;

ANIMAL; APOPTOSIS; BREAST; BREAST TUMOR; CELL DIFFERENTIATION; CELL DIVISION; CYTOLOGY; ENZYMOLOGY; EXPERIMENTAL NEOPLASM; FEMALE; GENETICS; HUMAN; METABOLISM; MOUSE; PATHOLOGY; PHYSIOLOGY; PRECANCER; REVIEW; UDDER;

ANIMALS; APOPTOSIS; BREAST; BREAST NEOPLASMS; CELL DIFFERENTIATION; CELL DIVISION; FEMALE; HUMANS; MAMMARY GLANDS, ANIMAL; MAMMARY NEOPLASMS, EXPERIMENTAL; MATRIX METALLOPROTEINASES; MICE; PRECANCEROUS CONDITIONS;

EID: 0032034477     PISSN: 10833021     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1018746923474     Document Type: Article

References (70)

1. H. Birkedal-Hansen (1995). Proteolytic remodeling of extracellular matrix. Curr. Opin. Cell Biol. 7:728-735.
2. D. Q. Pei and S. J. Weiss (1996). Transmembrane-deletion mutants of the membrane-type matrix metalloproteinase-1 process progelatinase A and express intrinsic matrix-degrading activity. J. Biol. Chem. 271:9135-9140.
3. E. Ohuchi, K. Imai, Y. Fujii, H. Sato, M. Seiki, and Y. Okada (1997). Membrane type I matrix metalloproteinase digests interstitial collagens and other extracellular matrix macromolecules. J. Biol. Chem. 272:2446-2451.
4. H. E. Van Wart and H. Birkedal-Hansen (1990). The cysteine switch: A principle of regulation of metalloproteinase activity with potential applicability to the entire matrix metalloproteinase gene family. Proc. Natl. Acad. Sci. U.S.A. 87:5578-5582.
5. J. Greene, M. Wang, Y. E. Liu, L. A. Raymond, C. Rosen, and Y. E. Shi (1996). Molecular cloning and characterization of human tissue inhibitor of metalloproteinase 4. J. Biol. Chem. 271:30375-30380.
6. C. Wolf, N. Rouyer, Y. Lutz, C. Adida, M. Loriot, J.-P. Bellocq, P. Chambon, and P. Basset (1993). Stromelysin 3 belongs to a subgroup of proteinases expressed in breast carcinoma fibroblastic cells and possibly implicated in tumor progression. Proc. Natl. Acad. Sci. U.S.A. 90:1843-1847.
7. E. Hahnel, J. M. Harvey, R. Joyce, P. D. Robbins, G. F. Sterrett, and R. Hahnel (1993). Stromelysin-3 expression in breast cancer biopsies: Clinical-pathological correlations. Int. J. Cancer 55:771-774.
8. J. M. P. Freije, I. Diez-Itza, M. Balbin, L. M. Sanchez, R. Blasco, J. Tolivia, and C. Lopez-Otin (1994). Molecular cloning and expression of collagenase-3, a novel human matrix metalloprotienase produced by breast carcinomas. J. Biol. Chem. 269:16766-16773.
9. U. K. Saarialho-Kere, E. C. Crouch, and W. C. Parks (1995). The matrix metalloproteinase matrilysin is constitutively expressed in adult human exocrine epithelium. J. Invest. Dermatol. 105:190-196.
10. C. Monteagudo, M. J. Merino, J. San-Juan, L. A. Liotta, and W. G. Stetler-Stevenson (1990). Immunohistochemical distribution of type IV collagenase in normal, benign, and malignant breast tissue. Am. J. Pathol 136:585-592.
11. D. Medina (1996). The Mammary Gland: A unique organ for the study of development and tumorigenesis. J. Mam. Gland Biol. Neoplasia 1:5-19.
12. J. P. Witty, J. Wright, and L. M. Matrisian (1995). Matrix metalloproteinases are expressed during ductal and alveolar mammary morphogenesis, and misregulation of stromelysin-1 in transgenic mice induces unscheduled alveolar development. Mol. Biol. Cell 6:1287-1303.
13. R. S. Talhouk, J. R. Chin, E. N. Unemori, Z. Werb, and M. J. Bissell (1991). Proteinases of the mammary gland: developmental regulation in vivo and vectorial secretion in culture. Development 112:439-449.
14. C. J. Sympson, R. S. Talhouk, C. M. Alexander, J. R. Chin, S. M. Clift, M. J. Bissell, and Z. Werb (1994). Targeted expression of stromelysin-1 in mammary gland provides evidence for a role of proteinases in branching morphogenesis and the requirement for an intact basement membrane for tissue-specific gene expression. J. Cell Biol. 125:681-693.
15. A. Metcalfe and C. H. Streuli (1997). Epithelial apoptosis. BioEssays 19:711-720.
16. R. S. Talhouk, M. J. Bissell, and Z. Werb (1992). Coordinated expression of extracellular matrix-degrading proteinases and their inhibitors regulates mammary epithelial function during involution. J. Cell Biol. 118:1271-1282.
17. S. R. Dickson and M. J. Warburton (1992). Enhanced synthesis of gelatinase and stromelysin by myoepithelial cells during involution of the rat mammary gland. J. Histochem. Cytochem. 40:697-703.
18. F. Li, R. Strange, R. R. Friis, V. Djonov, H. Altermatt, S. Saurer, H. Niemann, and A. Andres (1994). Expression of stromelysin-1 and TIMP-1 in the involuting mammary gland and in early invasive tumors of the mouse. Int. J. Cancer 59:560-568.
19. O. Lefebvre, C. Wolf, J.-M. Limacher, P. Hutin, C. Wendling, M. LeMeur, P. Basset, and M.-C. Rio (1992). The breast cancer-associated stromelysin-3 gene is expressed during mouse mammary gland apoptosis. J. Cell Biol. 119:997-1002.
20. M. J. Warburton, E. J. Ormerod, P. Monaghan, S. A. Ferns, and P. S. Rudland (1981). Characterization of a myoepithelial cell line derived from a neonatal rat mammary gland. J. Cell Biol. 91:827.
21. 1 integrin and its ligands, collagen I, collagen IV, and laminin, suggest important roles in mouse mammary morphogenesis. Differentiation 59:1-13.
22. L. M. Andersson, S. R. Dundas, M. J. O'Hare, B. A. Gusterson, and M. J. Warburton (1994). Synthesis of gelatinases by rat mammary epithelial and myoepithelial cell lines. Exp. Cell Res. 212:389-392.
23. C. L. Wilson, K. J. Heppner, L. A. Rudolph, and L. M. Matrisian (1995). The metalloproteinase matrilysin is preferentially expressed by epithelial cells in a tissue-restricted pattern in the mouse. Mol. Biol. Cell 6:851-869.
24. S. R. Ross, C. L. L. Hsu, Y. Choi, E. Mok, and J. P. Dudley (1990). Negative regulation in correct tissue-specific expression of mouse mammary tumor virus in transgenic mice. Mol. Cell. Biol. 10:5822-5829.
25. H. L. Nakhasi and P. K. Quasba (1979). Quantitation of milk proteins and their mRNAs in rat mammary gland at various stages of gestation and lactation. J. Biol. Chem. 254:6016-6025.
26. C.L. Wilson and L.M. Matrisian (1996). Matrilysin: An epithelial matrix metalloproteinase with potentially novel functions. Int. J. Biochem. Cell Biol. 28:123-136.
27. A. F. Chambers and L. M. Matrisian (1997). Changing views of the role of matrix metalloproteinases in metastasis. J. Natl. Cancer Inst. 89:1260-1270.
28. G. W. Sledge, Jr, M. Qulali, R. Goulet, E. A. Bone, and R. Fife (1995). Effect of matrix metalloproteinase inhibitor batimastat on breast cancer regrowth and metastasis in athymic mice. J. Natl. Cancer Inst. 87:1546-1550.
29. S. A. Eccles, G. M. Box, W. J. Court, E. A. Bone, W. Thomas, and P. D. Brown (1996). Control of lymphatic and hematogenous metastasis of a rat mammary carcinoma by the matrix metalloproteinase inhibitor batimastat (BB-94). Cancer Res. 56:2815-2822.
30. B. Davies, P. D. Brown, N. East, M. J. Crimmin, and F. R. Balkwill (1993). A synthetic matrix metalloproteinase inhibitor decreases tumor burden and prolongs survival of mice bearing human ovarian carcinoma xenografts. Cancer Res. 53:2087-2091.
31. J. R. MacDougall and L. M. Matrisian (1995). Contributions of tumor and stromal matrix metalloproteinases to tumor progression, invasion and metastasis. Cancer Metastasis Rev. 14:351-362.
32. L. Ronnov-Jessen, O. W. Petersen, and M. Bissell (1996). Cellular changes involved in conversion of normal to malignant breast: Importance of the stromal reaction. Physiol. Rev. 76:69-125.
33. A. Lochter and M. J. Bissell (1995). Involvement of extracellular matrix constituents in breast cancer. Sem. Cell Biol. 6:165-173.
34. J. Strater, U. Wedding, T. F. Barth, K. Koretz, C. Elsing, and P. Moller (1996). Rapid onset of apoptosis in vitro follows disruption of beta 1 integrin/matrix interactions in human colonie crypt cells. Gastroenterology 110:1776-1784.
35. S. M. Frisch and H. Francis (1994). Disruption of epithelial cell-matrix interactions induces apoptosis. J. Cell Biol. 124:619-626.
36. N. Boudreau, C. J. Sympson, Z. Werb, and M. J. Bissell (1995). Suppression of interstitial collagenase and apoptosis in mammary epithelial cells by extracellular matrix. Science 267:891-893.
37. S. Pullan, J. Wilson, A. Metcalfe, G. M. Edwards, N. Goberdhan, J. Tilly, J. A. Hickman, C. Dive, and C. H. Streuli (1996). Requirement of basement membrane for the suppression of programmed cell death in mammary epithelium. J. Cell Sci. 109:631-642.
38. J. P. Witty, T. Lempka, R. J. Coffey, Jr., and L. M. Matrisian (1995). Decreased tumor formation in 7,12-dimethylbenzanthracene-treated stromelysin-1 transgenic mice is associated with alterations in mammary epithelial cell apoptosis. Cancer Res. 55:1401-1406.
39. C. M. Alexander, E. W. Howard, M. J. Bissell, and Z. Werb (1996). Rescue of mammary epithelial cell apoptosis and entactin degradation by a tissue inhibitor of metalloproteinase-1 transgene. J. Cell. Biol. 135:1669-1677.
40. L. A. Rudolph-Owen, P. Cannon, and L. M. Matrisian (1998). The overexpression of the matrix metalloproteinase matrilysin results in premature mammary gland differentiation and male infertility. Mol. Biol. Cell 9:421-435.
41. C. L. Wilson, K. J. Heppner, P. A. Labosky, B. L. M. Hogan, and L. M. Matrisian (1997). Intestinal tumorigenesis is suppressed in mice lacking the metalloproteinase matrilysin. Proc. Natl. Acad.Sci. U.S.A. 94:1402-1407.
42. P. Basset, J. P. Bellocq, C. Wolf, I. Stoll, P. Hutin, J. M. Limacher, O. L. Podhajcer, M. P. Chenard, M. C. Rio, and P. Chambon (1990). A novel metalloproteinase gene specifically expressed in stromal cells of breast carcinomas. Nature 348:699-704.
43. G. Engel, K. Heselmeyer, G. Auer, M. Bäckdahl, E. Eriksson, and S. Linder (1994). Correlation between stromelysin-3 mRNA level and outcome of human breast cancer. Int. J. Cancer 58:830-835.
44. P. Basset, C. Wolf, N. Rouyer, J.-P. Bellocq, M.-C. Rio, and P. Chambon (1994). Stromelysin-3 in stromal tissue as a control factor in breast cancer behavior. Cancer 74:1045-1049.
45. E.-Hähnel, H. Dawkins, P. Robbins, and R. Hähnel (1994). Expression of stromelysin-3 and nm23 in breast carcinoma and related tissues. Int. J. Cancer 58:157-160.
46. Y. Soini, T. Hurskainen, M. Höyhtyä, A. Oikarinen, and H. Autio-Harmainen (1994). 72 KD and 92 KD type IV collagenase, type IV collagen, and laminin mRNAs in breast cancer: A study by in situ hybridization. J. Histochem. Cytochem. 42:945-951.
47. M. Polette, N. Gilbert, I. Stas, B. Nawrocki, A. Nöel, A. Remacle, W. G. Stetler-Stevenson, P. Birembaut, and M. Foidart (1994). Gelatinase A expression and localization in human breast cancers. An in situ hybridization study and immunohistochemical detection using confocal microscopy. Virchows Arch. Int. J. Pathol. 424:641-645.
48. M. Polette, C. Clavel, M. Cockett, S. Girod de Bentzmann, G. Murphy, and P. Birembaut (1993). Detection and localization of mRNAs encoding matrix metalloproteinases and their tissue inhibitor in human breast pathology. Invasion Metastasis 13:31-37.
49. K. Tryggvason, M. Höyhtyä, and C. Pyke (1993). Type IV collagenases in invasive tumors. Br. Cancer Res. Treat. 24:209-218.
50. K. J. Heppner, L. M. Matrisian, R. A. Jensen, and W. H. Rodgers (1996). Expression of most matrix metalloproteinase family members in breast cancer represents a tumor-induced host response. Am. J. Pathol. 149:273-282.
51. P. D. Brown, R. E. Bloxidge, E. Anderson, and A. Howell (1993). Expression of activated gelatinase in human invasive breast carcinoma. Clin. Exp. Metastasis 11:183-189.
52. H. S. Azzam, G. A. Arand, M. E. Lippman, and E. W. Thompson (1993). Association of MMP-2 activation potential with metastatic progression in human breast cancer cell lines independent of MMP-2 production. J. Natl. Cancer Inst. 85:1758-1764.
53. H. Kolkenbrock, A. Heckerkia, D. Orgel, N. Ulbrich, and H. Will (1997). Activation of progelatinase A and progelatinase A TIMP-2 complex by membrane type 2 matrix metalloproteinase. Biol. Chem. 378:71-76.
54. H. Sato, T. Takino, V. Okada, J. Cao, A. Shinagawa, E. Yamamoto, and M. Seiki (1994). A matrix metalloproteinase expressed on the surface of invasive tumor cells. Nature 370:61-65.
55. A. Y. Strongin, B. L. Marmer, G. A. Grant, and G. I. Goldberg (1993) Plasma membrane-dependent activation of the 72-kDa type IV collagenase is prevented by complex formation with TIMP-2. J. Biol. Chem. 268:14033-14039.
56. D. W. Visscher, M. Höyhtyä, S. K. Ottosen, C.-M. Liang, F. H. Sarkar, J. D. Crissman, and R. Fridman (1994). Enhanced expression of tissue inhibitor of metalloproteinase-2 (TIMP-2) in the stroma of breast carcinomas correlates with tumor recurrence. Int. J. Cancer 59:339-344.
57. H. Ueno, H. Nakamura, M. Inoue, K. Imai, M. Noguchi, H. Sato, M. Seiki, and Y. Okada (1997). Expression and tissue localization of membrane-types 1,2, and 3 matrix metalloproteinases in human invasive breast carcinomas. Cancer Res. 57:2055-2060.
58. M. Polette, C. Gilles, V. Marchand, M. Seiki, J. M. Tournier, and P. Birembaut (1997). Induction of membrane-type matrix metalloproteinase 1 (MT1-MMP) expression in human fibroblasts by breast adenocarcinoma cells. Clin. Exp. Metastasis 15:157-163.
59. H. Pulyaeva, J. Bueno, M. Polette, P. Birembaut, H. Sato, M. Seiki, and E. W. Thompson (1997). MT1-MMP correlates with MMP-2 activation potential seen after epithelial to mesenchymal transition in human breast carcinoma cells. Clin. Exp. Metastasis 15:111-20.
60. X. S. Puente, A. M. Pendas, E. Llano, G. Velasco, and C. Lopez-Otin (1996). Molcular cloning of a novel membrane-type matrix metalloproteinase from a human breast carcinoma. Cancer Res. 56:944-949.
61. C. Gilles, M. Polette, M. Seiki, P. Birembaut, and E. W. Thompson (1997). Implication of collagen type 1-induced membrane-type 1 matrix metalloproteinase expression and matrix metalloproteinase-2 activation in the metastatic progression of breast carcinoma. Lab. Invest. 76:651-660.
62. M. Wang, Y. E. Liu, J. Greene, S. Sheng, A. Fuchs, E. M. Rosen, and Y. E. Shi (1997). Inhibition of tumor growth and metastasis of human breast cancer cells transfected with tissue inhibitor of metalloproteinase 4. Oncogene 14:2767-2774.
63. A. C. Noel, O. Lefebvre, E. Maquoi, L. Van Hoorde, M. P. Chenard, M. Mareel, J. M. Foidart, P. Basset, M. C. Rio, and L. Vanhoorde (1996). Stromelysin-3 expression promotes tumor take in nude mice. J. Clin. Invest. 97:1924-1930.
64. A. Lochter, A. Srebrow, C. J. Sympson, N. Terracio, Z. Werb, and M. J. Bissell (1997). Misregulation of stromelysin-1 expression in mouse mammary tumor cells accompanies acquisition of stromelysin-1-dependent invasive properties. J. Biol. Chem. 272:5007-5015.
65. M. D. Sternlicht, J. Xie, C. Sympson, M. Bissell, and Z. Werb (1997). Mice that express an autoactivating stromelysin-1 transgene develop progressive mammary gland lesions [Abstract]. Proc. Am. Ass. for Cancer Res. 38:257.
66. L. A. Rudolph-Owen, R. Chan, W. J. Muller, and L. M. Matrisian (1998). The matrix metalloproteinase matrilysin accelerates mammary tumorigenesis. (submitted).
67. C. W. Daniel and G. B. Silberstein. (1987). The mammary gland development, regulation, and function. In M. C. Neville and C. W. Daniel (eds.), Development of the Rodent Mammary Gland, Plenum Press, New York, pp. 3-36.
68. R. D. Cardiff (1984). Protoneoplasia: The molecular biology of murine mammary hyperplasia. Adv. Cancer Res, 42:167-190.
69. T. Yoneda, A. Sasaki, C. Dunstan, P. J. Williams, F. Bauss, Y. A. DeClerck, and G. R. Mundy (1997). Inhibition of osteolytic bone metastasis of breast cancer by combined treatment with the bisphosphonate ibandronate and tissue inhibitor of the matrix metalloproteinase-2. J. Clin. Invest. 99:2509-2517.
70. S. Koop, R. Khokha, E. E. Schmidt, I. C. MacDonald, V. L. Morris, A. F. Chambers, and A. C. Groom (1994). Overexpression of metalloproteinase inhibitor in B16F10 cells does not affect extravasation but reduces tumor growth Cancer Res, 54:4791-4797.